The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine

Misty Good, Chhinder Sodhi, Yukihiro Yamaguchi, Hongpeng Jia, Peng Lu, William B. Fulton, Laura Y. Martin, Thomas Prindle, Diego Nino, Qinjie Zhou, Congrong Ma, John A. Ozolek, Rachael H. Buck, Karen C. Goehring, David Hackam

Research output: Contribution to journalArticle

Abstract

Necrotising enterocolitis (NEC) is a common disease in premature infants characterised by intestinal ischaemia and necrosis. The only effective preventative strategy against NEC is the administration of breast milk, although the protective mechanisms remain unknown. We hypothesise that an abundant human milk oligosaccharide (HMO) in breast milk, 2'-fucosyllactose (2'FL), protects against NEC by enhancing intestinal mucosal blood flow, and we sought to determine the mechanisms underlying this protection. Administration of HMO-2'FL protected against NEC in neonatal wild-type mice, resulted in a decrease in pro-inflammatory markers and preserved the small intestinal mucosal architecture. These protective effects occurred via restoration of intestinal perfusion through up-regulation of the vasodilatory molecule endothelial nitric oxide synthase (eNOS), as administration of HMO-2'FL to eNOS-deficient mice or to mice that received eNOS inhibitors did not protect against NEC, and by 16S analysis HMO-2'FL affected the microbiota of the neonatal mouse gut, although these changes do not seem to be the primary mechanism of protection. Induction of eNOS by HMO-2'FL was also observed in cultured endothelial cells, providing a link between eNOS and HMO in the endothelium. These data demonstrate that HMO-2'FL protects against NEC in part through maintaining mesenteric perfusion via increased eNOS expression, and suggest that the 2'FL found in human milk may be mediating some of the protective benefits of breast milk in the clinical setting against NEC.

Original languageEnglish (US)
Pages (from-to)1175-1187
Number of pages13
JournalThe British journal of nutrition
Volume116
Issue number7
StatePublished - Oct 1 2016

Keywords

  • 2′FL 2′-fucosyllactose
  • eNOS endothelial nitric oxide synthase
  • HMO human milk oligosaccharide
  • LPS lipopolysaccharide
  • NEC necrotising enterocolitis
  • TLR4 toll-like receptor 4
  • 2′-Fucosyllactose
  • Breast milk
  • Endothelial nitric oxide synthase
  • Human milk oligosaccharides
  • Necrotising enterocolitis

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Fingerprint Dive into the research topics of 'The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine'. Together they form a unique fingerprint.

  • Cite this